PFIZER INC Available-for-sale Securities and Held-to-maturity Securities
PFIZER INC (PFE) had Available-for-sale Securities and Held-to-maturity Securities of $13.82 billion as of 2018-04-01, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAndHeldToMaturitySecurities · last filed 2018-05-10
- 2018-04-01: Available-for-sale Securities and Held-to-maturity Securities $13.82B.
- 2017-12-31: Available-for-sale Securities and Held-to-maturity Securities $22.31B.
- 2016-12-31: Available-for-sale Securities and Held-to-maturity Securities $19.87B.
- 2014-09-28: Available-for-sale Securities and Held-to-maturity Securities $46.84B.
| Period end | Available-for-sale Securities and Held-to-maturity Securities |
|---|---|
| 2018-04-01 | $13.82B 10-Q · filed 2018-05-10 |
| 2017-12-31 | $22.31B 10-Q · filed 2018-05-10 |
| 2016-12-31 | $19.87B 10-K · filed 2018-02-22 |
| 2014-09-28 | $46.84B 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |